Joe Newell - 15 Sep 2021 Form 4 Insider Report for Atara Biotherapeutics, Inc. (ATRA)

Role
Chief Operations Officer
Signature
/s/ David Tucker, Attorney-in-Fact for Joe Newell
Issuer symbol
ATRA
Transactions as of
15 Sep 2021
Transactions value $
-$48,647
Form type
4
Filing time
17 Sep 2021, 16:36:55 UTC
Previous filing
31 Aug 2021
Next filing
24 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATRA Common Stock Sale -$48.6K -3.12K -2.53% $15.61* 120K 15 Sep 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction pursuant to Rule 10b5-1 Plan adopted September 14, 2020.
F2 The price in Column 4 is a weighted average sale price. The prices actually received ranged from $15.54 to $15.73. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.